Cite
HARVARD Citation
Segal, N. et al. (2019). Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort. European journal of cancer. pp. 154-161. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Segal, N. et al. (2019). Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort. European journal of cancer. pp. 154-161. [Online].